摘要:052详见(《南京医药股份有限公司2007年第三季度报告》)。......
171,760,970.01
| 财务费用
| 11,041,104.06
| 14,606,418.25
| 40,896,342.14
| 37,734,367.87
|
资产减值损失
| -4,468,197.01
| 935,073.24
| 3,542,592.72
| 4,193,402.14
|
加:公允价值变动收益
(损失以“-”号填列)
| 1,060,659.71
| -24,700.00
| 3,825,200.00
| 131,075.70
|
投资收益(损失以“-”号填列)
| 11,722,065.72
| 1,285,489.41
| 17,736,879.01
| 3,565,087.55
|
其中:对联营企业和合
营企业的投资收益
|
|
|
|
|
汇兑收益(损失以“-”号填列)
|
|
|
|
|
三、营业利润(亏损以“-”号填列)
| 25,929,994.19
| 7,563,830.68
| 71,398,835.25
| 27,910,382.16
|
加:营业外收入
| 631,824.92
| 3,917,058.84
关键字:
|